Somatopause: State of the art

Minerva Endocrinologica

Volumn 36, Issue 3, 2011, Pages 243-255

  Somma, C D I ^a   Brunelli, V ^b   Savanelli, M C ^b   Scarano, E ^b   Savastano, S ^b   Lombardi, G ^b   Colao, A ^b  

^a IRCCS SDN   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Aging; Growth hormon releasing hormone; Growth hormone; Insulin like growth factor I

Indexed keywords

GHRELIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE SECRETAGOGUE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

AGING; BODY FAT; CARDIOVASCULAR RISK; EVIDENCE BASED MEDICINE; EXERCISE TOLERANCE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE SECRETING CELL; HUMAN; LIFESPAN; MUSCLE MASS; NONHUMAN; QUALITY OF LIFE; REVIEW; STRENGTH;

ADIPOSITY; AGED; AGED, 80 AND OVER; AGING; BODY COMPOSITION; BONE AND BONES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CLIMACTERIC; EVIDENCE-BASED MEDICINE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN-LIKE GROWTH FACTOR I; LONGEVITY; QUALITY OF LIFE;

EID: 84255183219     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (124)

1. Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science 1997;278:419-24. (Pubitemid 27454418)
2. Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev 1993;14:20-39. (Pubitemid 23066530)
3. Chahal HS, Drake WM. The endocrine system and ageing. J Pathol 2007;211:173-80. (Pubitemid 46195515)
4. Brook CG, Hindmarsh PC. The somatotropic axis in puberty. Endocrinol Metab Clin North Am 1992;21:767-82. (Pubitemid 23005084)
5. Veldhuis JD, Iranmanesh A, Bowers CY. Joint mechanisms of impaired growth-hormone pulse renewal in aging men. J Clin Endocrinol Metab 2005,9:4177-83. (Pubitemid 41058194)
6. Sonntag WE, Forman LJ, Miki N, Trapp JM, Gottschall PE, Meites J. L-Dopa restores amplitude of growth hormone pulses in old male rats to that observed in young male rats. Neuroendocrinology 1982;34:163-8. (Pubitemid 12171597)
7. Takahashi S, Gottschall PE, Quigley KL, Goya RG, Meites J. Growth hormone secretory patterns in young, middle-aged and old female rats. Neuroendocrinology 1987;46:137-42. (Pubitemid 17106411)
8. Dobado-Berrios PM, Ruiz-Navarro A, Almaden Y, Malagon MM, Garrido JC, Ramirez-Gutierrez JL et al. Heterogeneity of growt hormone (GH)-producing cells in aging male rats: ultrastructure and GH gene expression in somatotrope subpopulations. Mol Cell Endocrinol 1996;118:181-91.
9. Corpas E, Harman SM, Pineyro MA, Roberson R, Blackman MR. Continuous subcutaneous infusions of growth hormone (GH) releasing hormone 1-44 for 14 days increase GH and insulinlike growth factor-I levels in old men. J Clin Endocrinol Metab 1993;76:134-8. (Pubitemid 23027567)
10. Corpas E, Harman SM, Pineyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice dail reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab 1992;75:530-5.
11. Chapman IM, Hartman ML, Pezzoli SS, Thorner MO. Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormonereleasing peptide mimetic, L-692,429, in older adults - a clinical research center study. J Clin Endocrin Metab 1996;81:2874-80. (Pubitemid 26323878)
12. Muller EE, Cella SG, Parenti M, Deghenghi R, Locatelli V, De Gennaro Colonna V et al. Somatotropic dysregulation in old mammals. Horm Res 1995;43:39-45.
13. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 1998;19:717-97. (Pubitemid 128506521)
14. Vahl N, Jorgensen JO, Jurik AG, Christiansen JS. Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults. J Clin Endocrinol Metab 1996;81:2209-15. (Pubitemid 26175948)
15. Veldhuis JD, Iranmanesh A. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep. Sleep 1996;19:S221-4. (Pubitemid 27138534)
16. Ceda GP, Valenti G, Butturini U, Hoffman AR. Diminished pituitary responsiveness to growth hormone-releasing factor in aging male rats. Endocrinology 1986;118:2109-14. (Pubitemid 16106819)
17. Sonntag WE, Hylka VW, Meites J. Impaired ability of old male rats to secrete growth hormone in vivo but not in vitro in response to hpGRF(1-44). Endocrinology 1983;113:2305-7. (Pubitemid 14213605)
18. Spik K, Sonntag WE. Increased pituitary response to somatostatin in aging male rats: relationship to somatostatin receptor number and affinity. Neuroendocrinology 1989;50:489-94. (Pubitemid 19249088)
19. Abribat T, Deslauriers N, Brazeau P, Gaudreau P. Alterations of pituitary growth hormone-releasing factor binding sites in aging rats. Endocrinology 1991;128:633-5.
20. Orrego JJ, Russell-Aulet M, Demott-Friberg R, Barkan AL. Semiquantification of hypothalamic GH-Releasing Hormone output in women: evidence for sexual dimorphism in the mechanism of the somatopause. J Clin Endocrinol Metab 2001;86.5485-90.
21. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E et al. Effects of sex and age on 24-hour profile of growth hormone secretion in men: importance of endogeneous estradiol concentrations. J Clin Endocrinol Metab 1987;64:51-8. (Pubitemid 17015877)
22. Ghigo E, Arvat E, Gianotti L, et al. Human ageing and the GH-IGF-I axis. J Pediatr Endocrinol Metab 1996;9:271-8.
23. Arvat E, Camanni F, Ghigo E. Age-related growth hormone-releasing activity of growth hormone secretagogues in humans. Acta Pediatr Suppl 1997;423.92-6.
24. Broglio F, Benso A, Castiglioni C, Gottero C, Prodam F, Destefanis S et al. The endocrine response toghrelin as a function of gender in humans in young and elderly subjects. J Clin Endocrinol Metab 2003;88:1537-42. (Pubitemid 36623367)
25. Corpas E, Barman SM, Blackman MR. Serum IGF-binding-3 is related to IGF-I, but not to spontaneous GH release, in healthy men. Horm Metab Res 1992;24:543-5.
26. Baumann G. Growth hormone binding protein. J Pediatr Endocrinol Metab 2001;14:355-75.
27. Veldhuis JD, Evans WS, Shah N, Story S, Bray MJ, Anderson SM. Proposed mechanisms of sex-steroid hormone neuromodulation in the human GH-IGF-I axis. In Veldhuis JD, Giustina A eds. Sex-steroid interaction with growth hormone. New York, NY: Springer; 1999. p. 93-121.
28. Bondanelli M, Ambrosio MR, Margutti A, Franceschetti P, Zatelli MC, Degli Uberti E. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone. Neuroendocrinology 2003;77:380-7. (Pubitemid 36831202)
29. Weltman A, Despres JP, Clasey JL, Weltman JY, Wideman L, Kanaley J et al. Impact of abnominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults. Metabolism 2003,52:73-80.
30. Blackman MR, Christmas C, Munzer T et al. Influence of testosterone on the GH-IGF-I axis in healthy elderly men. In: Veldhuis JD, Giustina A, editors. Sex-steroid interaction with growth hormone. New York, NY: Springer; 1999. p. 44-53.
31. Arvat E, Broglio F, Ghigo E Insulin-Ike growth factor: implication in aging. Drugs and Ageing 2000;16:29-40. (Pubitemid 30052707)
32. Waters DL, Yau CL, Montoya GD, Baumgartner R. Serum sex hormones, IGF-I, and IGFBP3 exert a sexually dimorphic effect on lean body mass in aging. J Gerontol A Biol Sci Med Sci 2003,58:648-52. (Pubitemid 36900173)
33. Rudman D, Rao UMP. In: Morley JE, Koverman SG, editors. Endocrinology and metabolism in the elderly. Oxford: Blackwell Scientific; 1992. p. 50-60.
34. Barzilai N, Gupta G. Interaction between aging and syndrome X: new insights on the pathophysiology of fat distribution. Ann N Y Acad Sci 1999;892:58-72.
35. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9. (Pubitemid 34251969)
36. Russell-Jones DL, Umpleby M. Protein metabolic action of insulin, growth hormone and insulin-like growth factor 1. Eur J Endocrinol 1996;135:631
37. Colao A, Cerbone G, Pivonello R, Klain M, Aimaretti G, Faggiano A et al. Growth hormone deficiency in elderly patients with hypothalamo-pituitary tumors. Pituitary 1998,1:59-67. (Pubitemid 128512314)
38. Colao A, Cuocolo A, Di Somma C, Cerbone G, Della Morte AM, Nicolai E et al. Impaired cardiac performance in elderly patients with growth hormone deficiency. J Clin Endocrinol Metab 1999;84:3950-5. (Pubitemid 30644179)
39. Johannsson G, Svensson J, Bengtsson BA. Growth hormone and ageing. Growth Horm IGF Res 2000;10(Suppl B):S25-30. (Pubitemid 30637213)
40. Lamberts SW. The somatopause: to treat or not to treat? Horm Res 2000;53(Suppl 3):42-3.
41. Savine R, Sonksen P. Growth hormone - hormone replacement for the somatopause? Horm Res 2000;53(Suppl 3):37-41.
42. Cummings DE, Merriam GR. Age-related changes in growth hormone secretion: should the somatopause be treated? Semin Reprod Endocrinol 1999;17:311-25.
43. Jorgensen JO Two hot topics in the field of GH therapy: quality of life in hypopituitary adults, and clinical implications of the somatopause. Report from an interactive discussion. J Endocrinol Invest 1999;22(5 Suppl):150-6.
44. Savine R, Sonksen PH. Is the somatopause an indication for growth hormone replacement? J Endocrinol Invest 1999;22(5 Suppl):142-9.
45. von Werder K. The somatopause is no indication for growth hormone therapy J Endocrinol Invest 1999;22(5 Suppl):137-41.
46. Lombardi G, Di Somma C, Rota F, Colao A. Associated hormonal decline in aging: is there a role for GH therapy in aging men? J Endocrinol Invest 2005;28(3 Suppl):99-108.
47. Lieberman SA, Hoffman AR. The somatopause: should growth hormone deficiency in older people Be treated? Clin Geriatr Med 1997;13:671-84. (Pubitemid 28006832)
48. Hoffman AR, Ceda GP. IGFs and aging: is there a rationale for hormone replacement therapy? Growth Horm IGF Res 2004;14:296-300 (Pubitemid 38878055)
49. Ghigo E, Arvat E, Aimaretti G, Broglio F, Giordano R, Camanni F. Diagnostic and therapeutic uses of growth hormone-releasing substances in adult and elderly subjects. Baillieres Clin Endocrinol Metab 1998;12:341-58. (Pubitemid 29051950)
50. Muller EE, Rigamonti AE, Colonna Vde G, Locatelli V, Berti F, Cella SG. GH-related and extra-endocrine actions of GH secretagogues in aging. Neurobiol Aging 2002;23:907-19. (Pubitemid 35217716)
51. Lombardi G, Tauchmanova L, Di Somma C, Musella T, Rota F, Savanelli MC et al. Somatopause: dismetabolic and bone effects. J Endocrinol Invest 2005;28(10 Suppl):36-42.
52. Rudman D. Growth hormone, body composition and aging. J Am Geriatr Soc 1985;33:800-7. (Pubitemid 16183980)
53. Borkan GA, Hults DE, Gerof SG, Robbins AH, Silbert CK. Age related changes in body composition revealed by computed tomography. J Geront 1983;38:673-7. (Pubitemid 13023392)
54. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285-8. (Pubitemid 20229130)
55. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001;357:425-31.
56. Colao A, Di Somma C, Marzullo P, Lombardi G. Growth hormone and the heart. Clin Endocrinol (Oxf) 2001;54:137-54. (Pubitemid 32194446)
57. Vasan RS, Sullivan LM, D'Agostino RB, Roubenoff R, Harris T, Sawyer DB et al. Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med 2003;139:642-8.
58. Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab 2004;89:114-20. (Pubitemid 38183869)
59. Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart: myocyte loss and reactive cellular hypertrophy. Circ Res 1991;68:1560-8.
60. Wei JY. Age and cardiovascular system. N Engl J Med 1999; 2327:1735-9.
61. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147:755-63. (Pubitemid 28183275)
62. Sullivan DH. The role of nutrition in increased morbidity and mortality. Clin Geriatr Med 1995;11:661-74.
63. Broglio F, Gottero C, Arvat E, Ghigo E. Endocrine and non-endocrine actions of ghrelin. Horm Res 2003;59:109-17. (Pubitemid 36359407)
64. Rudman D, Feller AG, Hoskote S, Nagraj HS, Gergans GA, Lalitha PY et al. Effects of growth hormone in men over 60 years old. N Engl J Med 1990;323:1-6. (Pubitemid 20209464)
65. Rudman D, Feller AG, Cohn L, Shetty KR, Rudman IW, Draper MW. Effects of human growth hormone on body composition in elderly men. Horm Res 1991;36(Suppl 1):73-81.
66. Kaiser FE, Silver AJ, Morley JE. The effect of recombinant human growth hormone on malnourished older individuals. J Am Geriatr Soc 1991;39:235-40.
67. Von Werder K. Growth hormone therapy in prostatic cancer: preliminary results. In: Ranke MB, Christiansen JS, editors. The complexity of endocrine systems. Mannheim: J&J Verlag; 1996. p 163.
68. Papadakis MA, Grady D, Black D, Tierny MJ, Gooding GAW, Schamblean M, Grunfeld C. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 1996;124:708.
69. Welle S, Thornton C, Scott M, McHenry B. Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old. J Clin Endorinol Metab 1996;81:3239.
70. Karlsson C, Stenlof K, Johannsson G, Marin P, Bjorntorp P, Bengtsson BA et al. Effects of growth hormone treatment on the leptin system and on energy expenditure in abdominally obese men. Eur J Endocrinol 1998;138:408-14. (Pubitemid 28179371)
71. Lange KH, Isaksson F, Rasmussen MH, Juul A, Bulow J, Kjaer M. GH administration and discontinuation in healthy elderly men: effects on body composition, GH-related seaim markers, resting heart rate and resting oxygen uptake. Clin Endocrinol (Oxf) 2001;55:77-86. (Pubitemid 34204302)
72. Taaffe DR, Pruitt L, Reim J, Hintz RL, Butterfield G, Hoffman AR et al. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab 1994;79:1361-6. (Pubitemid 24369849)
73. Lange KH, Andersen JL, Beyer N, Isaksson F, Larsson B, Rasmussen MH et al. GH administration changes myosin heavy chain isoforms in skeletal muscle but does not augment muscle strength or hypertrophy, either alone or combined with resistance exercise training in healthy elderly men. J Clin Endocrinol Metab 2002;87:513-23. (Pubitemid 34158213)
74. Blackman MR, Sorkin JD, Münzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 2002;288:2282-92. (Pubitemid 35291758)
75. Anawalt BD, Merriam GR. Neuroendocrine aging in men:Andropause and Somatopause Endocrinol Metab Clin North Am 2001;30:647-69.
76. Park JK, Hong JW, Kim CO, Kim SW, Lim CY, Chung YS et al. Sustained-release recombinant human growth hormone improves body composition and quality of life in adults with somatopause. J Am Geriatr Soc 2011;33:334-7.
77. Garnero P, Sornay-Rendu E, Chapuy MC, Del Mas PD. Increased bone turnover in late postmenopausal women is a major determination of osteoporosis. J Bone Miner Res 1996;11:337-49. (Pubitemid 26076383)
78. Schacht E. Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroie-induced osteoporosis with alfacalcidiol. Calcif Tissue Int 1999;65:317-27. (Pubitemid 29471014)
79. Holloway L, Kohlmeier L, Kent K, Marcus R. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women. J Clin Endocrinol Metab 1997;82:1111-7. (Pubitemid 27166651)
80. Marcus R. Recombinant human growth hormone as potential therapy for osteoporosis [Review] Baill Clin Endocirnol Metab 1998;12:251-60. (Pubitemid 29051944)
81. Van der Lely AJ, Lamberts SW, Jauch KW, Swierstra BA, Hertlein H, Danielle De Vries D et al. Use of human GH in elderly patients with accidental hip fracture. Eur J Endocrinol 2000;143:585-92.
82. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R. Effect of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab 1994;79:470-9. (Pubitemid 24256538)
83. Christmas C, O'Connor KG, Harman SM, Tobin JD, Münzer T, Bellantoni MF et al. Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men. J Gerontol A Biol Sci Med Sci 2002;57:M12-8. (Pubitemid 34074441)
84. Wüster C, Härle U, Rehn U, Müller C, Knauf K, Köppler D et al. Benefits of growth hormone treatment on bone metabolism, bone density and bone strength in growth hormone deficiency and osteoporosis. Growth Horm IGF Res 1998;8(Suppl A):87-94.
85. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J CLin Endocrinol Metab 1994;78:669-74. (Pubitemid 24083309)
86. Hyer SI, Rodin DA, Tobias JH, Leiper A, Nussey SS. Growth hormone deficiency during puberty reduces adult bone mineral density. Arch Dis Child 1992;67:1472-4. (Pubitemid 23008273)
87. Toogood AA, Adams JE, O'Neill PA, Shalet SM. Elderly patients with adult onset growth hormone deficiency are not osteopenic. J Clin Endocrinol Metab 1997;82:1462-6. (Pubitemid 27200419)
88. Kaji H, Abe H, Fukase M, Chihara K. Normal bone mineral density in patients with adult onset GH deficiency. Endocrinol Metab 1997;4:163-6. (Pubitemid 27459709)
89. Orwoll ES, Bell NH, Nanes MS, Flessland KA, Pettinger MB, Mallinak NJS, Cain D. Collagen N-telopeptide excretion in men: the effects of age and intrasubject variability. J Clin Endocrinol Metab 1998,83:3930-5. (Pubitemid 28513575)
90. Szulc P, Garnero P, Munoz F, Marchand F, Delmas PD. Cross-sectional evaluation of bone metabolism in men. J Bone Miner Res 2001;16:1642-50. (Pubitemid 32786433)
91. Yarasheski KE, Zachwieja JJ, Campbell JA, Bier DM. Effect of growth hormone and resistance exercise on muscle growth and strength in older men. Am J Physiol 1995;268.E268-E76.
92. Sartorio A, Conti A, Molinari E, Riva G, Morabito F, Faglia G. Growth, growth hormone and cognitive functions. Horm Res 1996;45:23-9. (Pubitemid 26034759)
93. Liu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med 2007;146:104-15. (Pubitemid 351640014)
94. Nyberg F, Burman P. Growth hormone and its receptors in the central nervous system-location and functional significance. Horm Res 1996;45:18-22. (Pubitemid 26034758)
95. Kalmijn S, Janssen JA, Pols HA, Lamberts SW, Breteler MM. A prospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly. J Clin Endocrinol Metab 2000;85:4551-5. (Pubitemid 32157632)
96. Paolisso G, Ammendola S, Del Buono A. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. J Clin Endocrinol Metab 1997;82: 2204-9. (Pubitemid 27287585)
97. Aleman A, de Vries WR, de Haan EH, Verhaar HJ, Samson MM, Koppeschaar HP. Age-sensitive cognitive function, growth hormone and insulin-like growth factor 1 plasma levels in healthy older men. Neuropsychobiol 2000;41:73-8. (Pubitemid 30058127)
98. Friedlander AL, Butterfield GE, Moynihan S. One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women. J Clin Endocrinol Metab 2001;86:1496-503. (Pubitemid 32374893)
99. Giordano R, Bonelli L, Marinazzo E, Ghigo E, Arvat E. Growth hormone treatment in human ageing: benefits and risks. Hormones 2008;7:133-9.
100. Blackman MR Age-related alterations in sleep quality and neuroendocrine function. J Am Med Assoc 2000;28:48-9.
101. Weissberger AJ, Anastasiadis AD, Sturgess I, Martin FC, Smith MA, Sonksen PH. Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement. Clin Endocrinol (OxO 2003;58:99-107.
102. Johannsson G, Bengtsson BA, Ahlmen J. Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: anabolic effect and functional improvement. Am J Kidney Dis 1999;33:709-17. (Pubitemid 29159937)
103. Arvat E, Ceda G, Ramunni J, Lanfranco F, Aimaretti G, Gianotti L et al. The IGF-I response to very low rhGH doses is preserved in human ageing. Clin Endocrinol (Oxf) 1998;49:757-63. (Pubitemid 29009505)
104. Drake WM, Howell SJ, Monson JP, Shalet SM. Optimizing GH therapy in adults and children. Endocr Rev 2001;22:425-50. (Pubitemid 32762322)
105. Ruiz-Torres A, Soares de Melo Kirzner M. Ageing and longevity are related to growth hormone/ insulin-like growth factor-1 secretion. Gerontology 2002;48:401-7. (Pubitemid 36152992)
106. Holzenberger M. The GH/IGF-I axis and longevity. Eur J Endocrinol 2004;151(Suppl 1):S23.
107. Carter CS, Ramsey MM, Ingram RL, Cashion AB, Cefalu WT, Wang ZQ et al. Models of growth hormone and IGF-1 deficiency: applications to studies of aging processes and life-span determination. J Gerontol A Biol Sci Med Sci 2002;57:B177-88. (Pubitemid 34464960)
108. Kayo T, Allison DB, Weindruch R, Prolla TA. Influences of aging and caloric restriction on the transcriptional profile of skeletal muscle from rhesus monkeys. Proc Natl Acad Sci U S A 2001;98:5093-8. (Pubitemid 32397088)
109. Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003;421:182-7. (Pubitemid 36090987)
110. Bluher M, Kahn BB, Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissue Science. 2003; 299:572-4 (Pubitemid 36135156)
111. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 2003; 35:694-704. (Pubitemid 38058173)
112. Svensson J, Bengtsson BA, Rosen T, Oden A, Johannsson G. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. J Clin Endocrinol Metab 2004;89:3306-12. (Pubitemid 38960692)
113. Abs R, Bengtsson BA, Hernberg-Stahl E, Monson JP, Tauber JP, Wilton P et al. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin Endocrinol (Oxf) 1999;50:703-13, (Pubitemid 29284503)
114. Attanasio AF, Bates PC, Ho KK, Webb SM, Ross RJ, Strasburger CJ et al.; Hypoptiuitary control and complications study international advisory board. Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status - 3-year results from the HypoCCS Database. J Clin Endocrinol Metab 2002;87:1600-6. (Pubitemid 34618501)
115. Sklar CA. Growth hormone treatment: cancer risk. Horm Res 2004;62(Suppl 3):30-4.
116. Guldner J, Schier T, Friess E, Colla M, Holsboer F, Steiger A. Reduced efficacy of growth hormone-releasing hormone in modulating sleep endocrine activity in the elderly. Neurobiol Aging 1997;18:491-5. (Pubitemid 27497145)
117. Steiger A, Guldner J, Hemmeter U, Rothe B, Wiedemann K, Holsboer F. Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls. Neuroendocrinology 1992;56:566-73.
118. Marshall L, Molle M, Boschen G, Steiger A, Fehm HL, Born J. Greater efficacy of episodic than continuous growth hormone-releasing hormone (GHRH) administration in promoting slow-wave sleep (SWS). J Clin Endocrinol Metab 1996;81:1009-13. (Pubitemid 26083962)
119. Perras B, Marshall L, Kohler G, Born J, Fehm HL. Sleep and endocrine changes after intranasal administration of growth hormone-releasing hormone in young and aged humans. Psychoneuroendocrinology 1999;24:743-57. (Pubitemid 29378501)
120. Veldhuis JD, Patrie JT, Frick K, Weltman JY, Weltman A. Sustained Growth Hormone (GH) and Insulin-Like Growth Factor I Responses to Prolonged High-Dose Twice-Daily GH-Releasing Hormone Stimulation in Middle-Aged and Older Men. J Clin Endocrinol Metab 2004;89:6325-30. (Pubitemid 39628454)
121. Nargund RP, Patchett AA, Bach MA, Murphy MG, Smith RG. Peptidomimetic growth hormone secretagogues. Design considerations and therapeutic potential. J Med Chem 1998;41:3103-27. (Pubitemid 28376519)
122. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-60. (Pubitemid 129516334)
123. Broglio F, Benso A, Castiglioni C, Gottero C, Prodam F, Destefanis S et al. The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. J Clin Endocrinol Metab 2003;88:1537-42. (Pubitemid 36623367)
124. Morley JE. Anorexia, sarcopenia, and aging. Nutrition 2001;17:660-3. (Pubitemid 32640158)